Coralie Katharina Dicks1, Gerhard-Paul Diller1, Kristina Wasmer2, Paul C. Helm3,4, Ulrike M. M. Bauer3,4, Helmut Baumgartner1, Stefan Orwat1,#, Alicia Jeanette Fischer1,#,*
Congenital Heart Disease, Vol.15, No.2, pp. 117-125, 2020, DOI:10.32604/CHD.2020.011520
- 23 June 2020
Abstract Background: Sudden cardiac death is a leading cause of death in
patients with congenital heart disease (CHD). Risk stratification for implantable
cardioverter defibrillators (ICD) remains difficult due to limited data about use
and outcome of device therapy in CHD patients in larger community-based
cohorts. Methods and results: Out of a dataset with more than 50,000 patients
registered at the German National Register for Congenital Heart Defects, 109
patients (median age 35.5; IQR 23.75–46.00), 68 (62%) male) with an ICD were
identified and were retrospectively analyzed. Although the number of
implantations increased steadily throughout the investigated time interval… More >
Login
Register
